167,758 Shares in Astrana Health, Inc. $ASTH Purchased by 1492 Capital Management LLC

1492 Capital Management LLC bought a new position in shares of Astrana Health, Inc. (NASDAQ:ASTH) in the fourth quarter, HoldingsChannel reports. The firm bought 167,758 shares of the company’s stock, valued at approximately $4,162,000. Astrana Health makes up approximately 1.6% of 1492 Capital Management LLC’s investment portfolio, making the stock its 25th largest holding.

Several other hedge funds have also modified their holdings of ASTH. Signaturefd LLC increased its holdings in shares of Astrana Health by 57.9% during the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock worth $26,000 after buying an additional 388 shares during the last quarter. Thrivent Financial for Lutherans raised its holdings in shares of Astrana Health by 1.5% in the 3rd quarter. Thrivent Financial for Lutherans now owns 30,977 shares of the company’s stock worth $878,000 after purchasing an additional 455 shares during the period. Principal Financial Group Inc. lifted its stake in shares of Astrana Health by 0.3% in the 3rd quarter. Principal Financial Group Inc. now owns 222,985 shares of the company’s stock valued at $6,322,000 after purchasing an additional 611 shares in the last quarter. Savant Capital LLC grew its holdings in shares of Astrana Health by 2.2% during the 3rd quarter. Savant Capital LLC now owns 30,713 shares of the company’s stock worth $871,000 after purchasing an additional 649 shares during the period. Finally, GAMMA Investing LLC grew its holdings in shares of Astrana Health by 144.7% during the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock worth $37,000 after purchasing an additional 871 shares during the period. 52.77% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on ASTH. Zacks Research raised shares of Astrana Health from a “strong sell” rating to a “hold” rating in a research note on Wednesday, March 11th. Barclays upgraded Astrana Health from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $37.00 to $50.00 in a research note on Tuesday, May 26th. Truist Financial increased their target price on Astrana Health from $38.00 to $47.00 and gave the company a “buy” rating in a research note on Thursday, May 14th. Robert W. Baird set a $45.00 target price on Astrana Health in a report on Friday, May 8th. Finally, BTIG Research reissued a “buy” rating and set a $50.00 price target on shares of Astrana Health in a research report on Tuesday. Seven equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $45.00.

Astrana Health Stock Down 0.6%

Shares of Astrana Health stock opened at $36.70 on Thursday. The stock has a market capitalization of $2.04 billion, a price-to-earnings ratio of 60.16 and a beta of 1.00. Astrana Health, Inc. has a twelve month low of $18.08 and a twelve month high of $39.93. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 1.20. The business’s 50 day simple moving average is $32.87 and its 200-day simple moving average is $26.72.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings results on Thursday, May 7th. The company reported $0.74 EPS for the quarter, beating the consensus estimate of $0.29 by $0.45. The company had revenue of $965.10 million for the quarter, compared to analyst estimates of $949.21 million. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. Astrana Health’s revenue was up 55.6% compared to the same quarter last year. During the same quarter last year, the business earned $0.42 earnings per share. Equities research analysts forecast that Astrana Health, Inc. will post 1.25 earnings per share for the current year.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.